Search research articles
Contact Us
Filters
Showing results (81-90 of 196) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
Emily K Mader, Yoshihiro Maeyama, Yi Lin, et al.
The Journal of Clinical Investigation
|
July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy
Eleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
American Journal of Clinical Oncology
|
June 17, 2017
Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy
Jonas Paludo, Karen Fritchie, Candace L Haddox, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter
Pavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
Journal of Translational Medicine
|
May 23, 2022
The future of cancer immunotherapy for brain tumors: a collaborative workshop
Christine E Brown, Samantha Bucktrout, Lisa H Butterfield, et al.
International Journal of Oncology
|
March 27, 2012
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells
Alexey A Leontovich, Shuya Zhang, Cosima Quatraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2003
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer
Oday Hamid, Mary L Varterasian, Scott Wadler, et al.
Neuro-Oncology
|
November 18, 2011
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
Bret B Friday, S Keith Anderson, Jan Buckner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme
Jann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
The Journal of Biological Chemistry
|
August 24, 2012
Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm
Alexa M Dickson, John R Anderson, Michael D Barnhart, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 196) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
Emily K Mader, Yoshihiro Maeyama, Yi Lin, et al.
The Journal of Clinical Investigation
|
July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy
Eleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
American Journal of Clinical Oncology
|
June 17, 2017
Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy
Jonas Paludo, Karen Fritchie, Candace L Haddox, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter
Pavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
Journal of Translational Medicine
|
May 23, 2022
The future of cancer immunotherapy for brain tumors: a collaborative workshop
Christine E Brown, Samantha Bucktrout, Lisa H Butterfield, et al.
International Journal of Oncology
|
March 27, 2012
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells
Alexey A Leontovich, Shuya Zhang, Cosima Quatraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2003
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer
Oday Hamid, Mary L Varterasian, Scott Wadler, et al.
Neuro-Oncology
|
November 18, 2011
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
Bret B Friday, S Keith Anderson, Jan Buckner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme
Jann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
The Journal of Biological Chemistry
|
August 24, 2012
Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm
Alexa M Dickson, John R Anderson, Michael D Barnhart, et al.
Page
of 20